1. Home
  2. ZVRA vs DFP Comparison

ZVRA vs DFP Comparison

Compare ZVRA & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • DFP
  • Stock Information
  • Founded
  • ZVRA 2006
  • DFP 2013
  • Country
  • ZVRA United States
  • DFP United States
  • Employees
  • ZVRA N/A
  • DFP N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • DFP Investment Managers
  • Sector
  • ZVRA Health Care
  • DFP Finance
  • Exchange
  • ZVRA Nasdaq
  • DFP Nasdaq
  • Market Cap
  • ZVRA 381.0M
  • DFP 420.8M
  • IPO Year
  • ZVRA 2015
  • DFP N/A
  • Fundamental
  • Price
  • ZVRA $7.15
  • DFP $19.47
  • Analyst Decision
  • ZVRA Strong Buy
  • DFP
  • Analyst Count
  • ZVRA 8
  • DFP 0
  • Target Price
  • ZVRA $22.29
  • DFP N/A
  • AVG Volume (30 Days)
  • ZVRA 542.5K
  • DFP 56.2K
  • Earning Date
  • ZVRA 05-07-2025
  • DFP 01-01-0001
  • Dividend Yield
  • ZVRA N/A
  • DFP 6.73%
  • EPS Growth
  • ZVRA N/A
  • DFP N/A
  • EPS
  • ZVRA N/A
  • DFP N/A
  • Revenue
  • ZVRA $23,612,000.00
  • DFP N/A
  • Revenue This Year
  • ZVRA $267.44
  • DFP N/A
  • Revenue Next Year
  • ZVRA $90.10
  • DFP N/A
  • P/E Ratio
  • ZVRA N/A
  • DFP N/A
  • Revenue Growth
  • ZVRA N/A
  • DFP N/A
  • 52 Week Low
  • ZVRA $4.20
  • DFP $15.45
  • 52 Week High
  • ZVRA $9.76
  • DFP $19.31
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 45.68
  • DFP 46.14
  • Support Level
  • ZVRA $6.77
  • DFP $18.63
  • Resistance Level
  • ZVRA $7.22
  • DFP $19.61
  • Average True Range (ATR)
  • ZVRA 0.45
  • DFP 0.42
  • MACD
  • ZVRA -0.00
  • DFP 0.00
  • Stochastic Oscillator
  • ZVRA 61.74
  • DFP 59.07

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.

Share on Social Networks: